Moderna, Inc. (MRNA)
NASDAQ: MRNA · Real-Time Price · USD
48.12
+2.40 (5.25%)
At close: May 20, 2026, 4:00 PM EDT
48.25
+0.13 (0.27%)
Pre-market: May 21, 2026, 4:11 AM EDT

Moderna Revenue

Moderna had revenue of $389.00M in the quarter ending March 31, 2026, with 260.19% growth. This brings the company's revenue in the last twelve months to $2.23B, down -29.97% year-over-year. In the year 2025, Moderna had annual revenue of $1.94B, down -39.93%.

Revenue (ttm)
$2.23B
Revenue Growth
-29.97%
P/S Ratio
8.58
Revenue / Employee
$473,404
Employees
4,700
Market Cap
19.09B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20251.94B-1.29B-39.93%
Dec 31, 20243.24B-3.61B-52.75%
Dec 31, 20236.85B-12.42B-64.45%
Dec 31, 202219.26B792.00M4.29%
Dec 31, 202118.47B17.67B2,200.25%
Dec 31, 2020803.00M743.00M1,238.33%
Dec 31, 201960.00M-75.07M-55.58%
Dec 31, 2018135.07M-70.76M-34.38%
Dec 31, 2017205.83M97.43M89.88%
Dec 31, 2016108.40M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Incyte5.36B
Jazz Pharmaceuticals4.44B
Genmab3.90B
BioNTech SE3.23B
Royalty Pharma2.44B
Exelixis2.38B
Ascendis Pharma998.25M
Insmed819.56M
Revenue Rankings